Rigel Pharma (RIGL) Tops Q3 EPS by 146c

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• UBS Reiterates Neutral Rating on Lazard (LAZ)
• Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'